| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2136242 | Journal of Bone Oncology | 2013 | 10 Pages |
Abstract
In conclusion, the use of a xenogenic model of Ewing's sarcoma allowed discriminating between the tumor and host cells responsible for the elevation of RANKL production observed in this tumor and demonstrated the relevance of blocking RANKL by OPG as a promising therapy in ES.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gaëlle Picarda, Etienne Matous, Jérôme Amiaud, Céline Charrier, François Lamoureux, Marie-Françoise Heymann, Franck Tirode, Bruno Pitard, Valérie Trichet, Dominique Heymann, Françoise Redini,